Literature DB >> 31548220

Cancer Cell Dormancy in Metastasis.

Matthew A Summers1,2, Michelle M McDonald1,2, Peter I Croucher1,2.   

Abstract

Recurrent metastasis following extended periods of disease-free survival remains a common cause of morbidity and mortality for many cancer patients. Recurrence is thought to be mediated by tumor cells that escaped the primary site early in the disease course and colonize distant organs. In these locations, cells adapt to the local environment, entering a state of long-term dormancy in which they can resist therapy. Then, through mechanisms that are poorly understood, a proportion of these cells are reactivated and become proliferative, forming lethal metastases. Here, we discuss disseminated tumor cell dormancy in recurrent metastasis. We discuss mechanisms known to control entrance of cells into dormancy, highlighting the relevant microenvironments or "niches" in which these cells reside and mechanisms known to be involved in dormant cell reactivation. Finally, we consider emerging therapeutic approaches aimed at eradicating residual disease and preventing metastatic relapse.
Copyright © 2020 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 31548220      PMCID: PMC7117952          DOI: 10.1101/cshperspect.a037556

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  75 in total

Review 1.  Integrins and angiogenesis.

Authors:  D G Stupack; D A Cheresh
Journal:  Curr Top Dev Biol       Date:  2004       Impact factor: 4.897

Review 2.  p38 MAP kinase's emerging role as a tumor suppressor.

Authors:  Dmitry V Bulavin; Albert J Fornace
Journal:  Adv Cancer Res       Date:  2004       Impact factor: 6.242

Review 3.  Dormant tumour cells, their niches and the influence of immunity.

Authors:  Erica T Goddard; Ivana Bozic; Stanley R Riddell; Cyrus M Ghajar
Journal:  Nat Cell Biol       Date:  2018-10-25       Impact factor: 28.824

4.  A niche-dependent myeloid transcriptome signature defines dormant myeloma cells.

Authors:  Weng Hua Khoo; Guy Ledergor; Assaf Weiner; Daniel L Roden; Rachael L Terry; Michelle M McDonald; Ryan C Chai; Kim De Veirman; Katie L Owen; Khatora S Opperman; Kate Vandyke; Justine R Clark; Anja Seckinger; Natasa Kovacic; Akira Nguyen; Sindhu T Mohanty; Jessica A Pettitt; Ya Xiao; Alexander P Corr; Christine Seeliger; Mark Novotny; Roger S Lasken; Tuan V Nguyen; Babatunde O Oyajobi; Dana Aftab; Alexander Swarbrick; Belinda Parker; Duncan R Hewett; Dirk Hose; Karin Vanderkerken; Andrew C W Zannettino; Ido Amit; Tri Giang Phan; Peter I Croucher
Journal:  Blood       Date:  2019-04-25       Impact factor: 22.113

5.  GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.

Authors:  Yusuke Shiozawa; Elisabeth A Pedersen; Lalit R Patel; Anne M Ziegler; Aaron M Havens; Younghun Jung; Jingcheng Wang; Stephanie Zalucha; Robert D Loberg; Kenneth J Pienta; Russell S Taichman
Journal:  Neoplasia       Date:  2010-02       Impact factor: 5.715

6.  Cancer cell-derived clusterin modulates the phosphatidylinositol 3'-kinase-Akt pathway through attenuation of insulin-like growth factor 1 during serum deprivation.

Authors:  Hakryul Jo; Yonghui Jia; Kulandayan K Subramanian; Hidenori Hattori; Hongbo R Luo
Journal:  Mol Cell Biol       Date:  2008-05-05       Impact factor: 4.272

7.  Long-term recurrence of soft tissue sarcomas: prognostic factors and implications for prolonged follow-up.

Authors:  Maud Toulmonde; Axel Le Cesne; Jean Mendiboure; Jean-Yves Blay; Sophie Piperno-Neumann; Christine Chevreau; Corinne Delcambre; Nicolas Penel; Philippe Terrier; Dominique Ranchère-Vince; Marick Lae; Sophie Le Guellec; Jean-Jacques Michels; Yves-Marie Robin; Carine Bellera; Antoine Italiano
Journal:  Cancer       Date:  2014-06-18       Impact factor: 6.860

8.  Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment.

Authors:  Olaia Naveiras; Valentina Nardi; Pamela L Wenzel; Peter V Hauschka; Frederic Fahey; George Q Daley
Journal:  Nature       Date:  2009-06-10       Impact factor: 49.962

9.  TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling.

Authors:  Paloma Bragado; Yeriel Estrada; Falguni Parikh; Sarah Krause; Carla Capobianco; Hernan G Farina; Denis M Schewe; Julio A Aguirre-Ghiso
Journal:  Nat Cell Biol       Date:  2013-10-27       Impact factor: 28.824

10.  Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche.

Authors:  Michelle A Lawson; Michelle M McDonald; Natasa Kovacic; Weng Hua Khoo; Rachael L Terry; Jenny Down; Warren Kaplan; Julia Paton-Hough; Clair Fellows; Jessica A Pettitt; T Neil Dear; Els Van Valckenborgh; Paul A Baldock; Michael J Rogers; Colby L Eaton; Karin Vanderkerken; Allison R Pettit; Julian M W Quinn; Andrew C W Zannettino; Tri Giang Phan; Peter I Croucher
Journal:  Nat Commun       Date:  2015-12-03       Impact factor: 14.919

View more
  9 in total

Review 1.  Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.

Authors:  Beatrice Aramini; Valentina Masciale; Giulia Grisendi; Federica Bertolini; Michela Maur; Giorgia Guaitoli; Isca Chrystel; Uliano Morandi; Franco Stella; Massimo Dominici; Khawaja Husnain Haider
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

2.  Long-term outcome of (neo)adjuvant zoledronic acid therapy in locally advanced breast cancer.

Authors:  Andrew P Jallouk; Sriram Paravastu; Katherine Weilbaecher; Rebecca L Aft
Journal:  Breast Cancer Res Treat       Date:  2021-02-16       Impact factor: 4.872

Review 3.  Translating the Science of Cancer Dormancy to the Clinic.

Authors:  Julio A Aguirre-Ghiso
Journal:  Cancer Res       Date:  2021-08-24       Impact factor: 12.701

4.  Emerging paradigms in metastasis research.

Authors:  Ashik Ahmed Abdul Pari; Mahak Singhal; Hellmut G Augustin
Journal:  J Exp Med       Date:  2021-01-04       Impact factor: 14.307

5.  Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humans.

Authors:  Andreas Brandl; Antonio G Solimando; Zeinab Mokhtari; Paula Tabares; Juliane Medler; Hannah Manz; Matteo Claudio Da Vià; Giorgio A Croci; Miriam Kurzwart; Sina Thusek; Theresa Schneider; Regina Ebert; Franz Jakob; Hermann Einsele; Andreas Beilhack
Journal:  Blood Adv       Date:  2022-04-12

6.  Cell-Penetrating CEBPB and CEBPD Leucine Zipper Decoys as Broadly Acting Anti-Cancer Agents.

Authors:  Qing Zhou; Xiotian Sun; Nicolas Pasquier; Parvaneh Jefferson; Trang T T Nguyen; Markus D Siegelin; James M Angelastro; Lloyd A Greene
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

Review 7.  Mesenchymal Stem Cell-Derived Extracellular Vesicles: Pleiotropic Impacts on Breast Cancer Occurrence, Development, and Therapy.

Authors:  Yiling Guo; Yujia Zhai; Longyuan Wu; Yazhuo Wang; Puzhen Wu; Lixia Xiong
Journal:  Int J Mol Sci       Date:  2022-03-08       Impact factor: 5.923

Review 8.  Isolated Pancreatic Metastases of Renal Cell Cancer: Genetics and Epigenetics of an Unusual Tumour Entity.

Authors:  Franz Sellner; Sabine Thalhammer; Martin Klimpfinger
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639

Review 9.  Principles of dormancy evident in high-grade serous ovarian cancer.

Authors:  Trevor G Shepherd; Frederick A Dick
Journal:  Cell Div       Date:  2022-03-23       Impact factor: 5.130

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.